Related references
Note: Only part of the references are listed.Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011
Peter Benn et al.
PRENATAL DIAGNOSIS (2012)
Technical standards and guidelines: Prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements
Glenn E. Palomaki et al.
GENETICS IN MEDICINE (2009)
Studying Early Lethality of 45,XO (Turner's Syndrome) Embryos Using Human Embryonic Stem Cells
Achia Urbach et al.
PLOS ONE (2009)
Screening for trisomy 18 by maternal age, fetal nuchal translucency, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Optimising management in Turner syndrome: from infancy to adult transfer
M. D. C. Donaldson et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2006)
Relation between increased fetal nuchal translucency thickness and chromosomal defects
KO Kagan et al.
OBSTETRICS AND GYNECOLOGY (2006)
Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials
SC Perni et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Incidence and spectrum of chromosome abnormalities in spontaneous abortions: New insights from a 12-year study
J Menasha et al.
GENETICS IN MEDICINE (2005)
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)
L Dugoff et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
First-trimester screening for trisomies 21 and 18
R Wapner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β-hCG and PAPP-A
K Spencer et al.
PRENATAL DIAGNOSIS (2002)
First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency
DA Krantz et al.
OBSTETRICS AND GYNECOLOGY (2000)
Share Paper
